Grace’s NF1 story - Nothing stops me
10 January 2022
My name is Grace, I am 18 years old. I was diagnosed with Neurofibromatosis Type 1 when I was 2 years old.
For me it has resulted in a few complications, such as an optic nerve glioma, scoliosis of the spine, café au lait marks and neurofibromas.
I had 18 months of chemotherapy to shrink the tumour behind my left eye, which unfortunately left me blind on that side. I’ve been in and out of hospital a lot over the years, with many MRI scans and appointments, but I’ve never let this stop me from doing anything.
Growing up, I was always active and had a love for swimming and triathlon. Due to my visual impairment, I was able to compete in the para category in my local triathlon club events and swimming galas.
My biggest accomplishment within sport was when I competed in the British Blind Sport National swimming championships in Birmingham, collecting a series of gold and silver medals over the years.
I am currently in my first year at university studying Health and Social which I hope will lead me into a career in which I can care for people, as I know personally how important the health and social care sector is and what a difference it can make.
Filter News
Lily: A little girl with a contagious smile
Learn all about Lily's NF1 diagnosis and how that led to incredible efforts to raise awareness and fundraise.
Read More
A New Collaboration: Ian Duggan British GT
Ian is racing in the British GT Championship, and will be sporting the NTUK Logo on his racing car and driving suit.
Read More
Lilly’s Story: Growing Up With NF1
In 2019, Lilly and her family featured in our ‘Shine a Light on Neurofibromatosis’ short film. Find out how she's getting on.
Read More
Improving the delivery of Genetic Results Survey
Survey: How did you receive your genetic results? Could we do it better?
Read More
Sonny’s NF1 story
Sonny, 3 years old, faces daily challenges but shows incredible strength, determination, and resilience. Read his story.
Read More
Great North Run 2026
Read more about this iconic half-marathon, and find out how to apply for 2027.
Read More
Manchester University NF1 MEK Inhibitors Research
Research: NF1 MEK Inhibitors and Learning
Read More